For the pain physician, Urine Drug Testing (UDT) is not a tool for “catching” patients; it is a critical safety intervention and an objective component of risk stratification. On the board exams, UDT questions are notoriously high-yield, focusing on the metabolic “family trees” of opioids and the technical differences between screening and confirmatory testing. Misinterpreting a UDT can lead to unnecessary treatment termination or, more dangerously, a failure to recognize life-threatening polypharmacy.

---

1. Types of Testing: Screening vs. Confirmatory

You must understand the two-step process of toxicology to answer board questions accurately.

I. Immunoassay (IA): The “Screen”

This is the standard “point-of-care” or “cup” test. It uses antibodies to detect the presence of a drug class.

• Pros: Fast, inexpensive, and high sensitivity.
• Cons: Low specificity. It often results in False Positives (e.g., poppy seeds triggering an opiate screen) or False Negatives (e.g., synthetic opioids like Fentanyl or Oxycodone often do not trigger a standard “Opiate” screen, which is designed to detect Morphine/Codeine).
• The “Opiate” Screen: This specifically looks for the 6-acetylmorphine core. It reliably detects Morphine, Codeine, and Heroin, but frequently misses Methadone, Oxycodone, and Fentanyl.

II. GC-MS and LC-MS: The “Confirmation”

Gas Chromatography-Mass Spectrometry (GC-MS) or Liquid Chromatography (LC-MS) is the gold standard.

• Pros: Extremely specific and sensitive. It identifies the exact molecular “fingerprint” and provides a quantitative level.
• Cons: Expensive and takes days to return.
• Board Pearl: If an Immunoassay is “Positive” but the patient denies use, the next logical step is always to order a confirmatory GC-MS/LC-MS.

---

2. The Opioid Metabolic Family Tree

This is perhaps the most tested area of pain medicine. You must know what a drug turns into to determine if a patient is taking their medication or an illicit substitute.

I. The “Natural” Opiates (The Morphine Group)

• Heroin –> 6-Monoacetylmorphine (6-MAM) –> Morphine.
  • High-Yield: 6-MAM has a half-life of less than 30 minutes. If you find it in the urine, it is definitive proof of recent heroin use.
• Codeine –> Morphine.
  • Clinical Logic: A patient prescribed Codeine should have Morphine in their urine.

II. The Semisynthetic Path

• Hydrocodone (Vicodin) –> Hydromorphone (Dilaudid).
  • Clinical Logic: A patient on Hydrocodone may have small amounts of Hydromorphone. However, a patient on Hydromorphone should not have Hydrocodone in their system.
• Oxycodone (Percocet)–> Oxymorphone (Opana).
  • Clinical Logic: Oxymorphone is an expected metabolite of Oxycodone.

III. The Synthetics (The “Lone Wolves”)

• Fentanyl –> Norfentanyl. (Does not cross-react with other opioids).
• Methadone –> EDDP. (Requires a specific methadone-only screen).

---

3. Interpreting Unexpected Results

False Positives (High-Yield for Boards)

Potential False Positive	Offending Agent(s)
Amphetamines	Pseudoephedrine, Selegiline, Bupropion, Trazodone
Benzodiazepines	Sertraline (Zoloft) – rare but tested
Opiates	Poppy seeds, Quinolone antibiotics (Levofloxacin)
PCP	Venlafaxine (Effexor), Dextromethorphan
Cannabinoids	NSAIDs (rare/historical), Dronabinol

False Negatives

• Dilution: Low Urinary Creatinine (< 20 mg/dL) or low Specific Gravity (< 1.003) suggests the patient may be drinking excessive water to “flush” the system or adding water to the cup.
• Synthetic Opioids: As mentioned, if you only order a “Standard 5-Panel,” you will miss Fentanyl and Oxycodone.

---

4. Behavioral Red Flags: “Adding” to the Cup

• Temperature: A fresh sample should be between 90F and 100F. Anything outside this range is a major red flag for “hand-warmers” or hidden samples.
• pH: Normal urine pH is between 4.5 and 8.0. Extremes suggest the addition of bleach or other adulterants.
• Absence of Metabolites: If a patient is prescribed Oxycodone and the UDT shows high levels of Oxycodone but zero Oxymorphone, it suggests they may have “scraped” a pill into the cup rather than actually ingesting it (lack of “first-pass” metabolism).

---

5. Clinical Integration: The “Pill Count” and Contract

In the PM&R and Pain setting, UDT is part of the Universal Precautions model:

1. Risk Screening: Use the ORT (Opioid Risk Tool) or SOAPP-R before prescribing.
2. Patient-Provider Agreement: A signed contract outlining the frequency of UDT and the consequences of “aberrant” results.
3. The “Dose-Response” in UDT: Remember that UDT is quantitative but not precise for timing. A high level does not necessarily mean the patient is “abusing,” and a low level does not always mean “diverting.” It is a piece of the clinical puzzle.

---

6. High-Yield Board “Fast Facts”

• 6-MAM: The “smoking gun” for Heroin use.
• Poppy Seeds: Can cause positive morphine results up to 2,000 ng/mL.
• Creatinine: Used to check for sample dilution (should be > 20 mg/dL).
• Immunoassay: High sensitivity, low specificity (the “Screen”).
• GC-MS: High sensitivity, high specificity (the “Confirmation”).
• Metabolic Tree: Codeine –> Morphine; Hydrocodone –> Hydromorphone; Oxycodone –>Oxymorphone.
• EDDP: The primary metabolite of Methadone.